Genital Herpes Vaccine To Be Tested

A study sponsored by the National Institutes of Health will evaluate the effectiveness of a vaccine believed to prevent genital herpes in women. The study will focus specifically on women aged 18 to 30 years old who have not contracted herpes. Nationwide, more than 7,500 women will participate at more than 20 sites.

Back to news